Product Information
LEVETIRACETAM 100 MG/ML SOLN is a generic product labeled by Camber Pharmaceuticals Inc., priced at $0.0301 per ML under NDC 31722057447. Its NADAC has been published 671 times since Nov 28, 2013.
FDA first approved this application on Feb 28, 2013. Its Orange Book therapeutic-equivalence code is AA.
Strength
100 mg/mL
Manufacturer
Camber Pharmaceuticals Inc.NDC
31722057447
Classification
Generic
Dosage Form
SOLUTION
Route
ORAL
Effective Date
9/23/2026
Active Ingredients
LEVETIRACETAMApproval Type
Generic (ANDA)
FDA Application
ANDA203052FDA Approved
2/28/2013
TE Code
AA
On Market Since
6/11/2015
Pharmacological Classes
Price Statistics
The NADAC for LEVETIRACETAM 100 MG/ML SOLN has been published 671 times since Nov 28, 2013, and over the history we have for it it has declined 49.3%. The table below summarizes its recorded NADAC range and movement.
| Current price | $0.0301 per ML |
|---|---|
| All-time high | $0.0635 (Feb 12, 2014) |
| All-time low | $0.0248 (Nov 20, 2024) |
| 52-week high | $0.0316 |
| 52-week low | $0.0301 |
| Median price | $0.0349 |
| Average price | $0.0378 |
| Largest weekly change | -20.4% (Nov 20, 2024) |
| Weeks tracked | 671 |
| Tracking since | Nov 28, 2013 |
Generic Alternatives
No other NADAC-published product shares this drug's active ingredient and strength in a comparable dosage form. Compare the broader picture on the Levetiracetam oral market page.
Lowest-Cost Alternatives
No alternatives available
Related Drugs
Same classification
Continue researching this drug
Use these direct paths to move from a single NDC into the surrounding market, manufacturer, class, and trend context.
Manufacturer
Camber Pharmaceuticals Inc. manufacturer profile
See the full portfolio, pricing trend, and other products from this labeler.
Drug market
Levetiracetam oral market comparison
Compare this molecule across participating manufacturers and inspect the broader market price spread.
Trend hub
Latest market trends
Zoom back out to the weekly mover view and compare this NDC with the rest of the current NADAC release.
Guide
Understanding NADAC pricing
Use the explainer when you need context on how CMS publishes NADAC and how to interpret the number on this page.
Frequently asked questions
What is the NADAC price of LEVETIRACETAM 100 MG/ML SOLN?
The current National Average Drug Acquisition Cost (NADAC) for LEVETIRACETAM 100 MG/ML SOLN, manufactured by Camber Pharmaceuticals Inc., is $0.0301 per ML (NDC 31722057447), effective Sep 30, 2026.
How has the price of LEVETIRACETAM 100 MG/ML SOLN changed over time?
Over the history we have for it, the NADAC for LEVETIRACETAM 100 MG/ML SOLN has declined 49.3%. It has been tracked across 671 weekly CMS publications since Nov 28, 2013.
What are the highest and lowest recorded NADAC prices for LEVETIRACETAM 100 MG/ML SOLN?
Since Nov 28, 2013, the NADAC for LEVETIRACETAM 100 MG/ML SOLN has ranged from a low of $0.0248 (Nov 20, 2024) to a high of $0.0635 (Feb 12, 2014), with a median of $0.0349 per ML.
Are there cheaper alternatives to LEVETIRACETAM 100 MG/ML SOLN?
No other NADAC-published product currently shares the active ingredient and strength of LEVETIRACETAM 100 MG/ML SOLN in a comparable dosage form, so no direct lower-cost alternative is listed.
Who manufactures LEVETIRACETAM 100 MG/ML SOLN?
LEVETIRACETAM 100 MG/ML SOLN (NDC 31722057447) is labeled by Camber Pharmaceuticals Inc., and CMS classifies it as a generic product.